Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/01/066
Active ingredient: Thalidomide
Indication: Treatment of erythema nodosum leprosum (ENL) or type II lepra reactions
Sponsor: Celgene Europe Limited
Riverside House, Riverside Walk, Windsor, Berkshire SL4 1NA, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2001 Centralised Orphan - Designation EMEA/OD/041/01 (2001)3568 of 20/11/2001
25/07/2005 Other procedure
02/12/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/041/01/T/01 (2008)7794 of 28/11/2008
09/11/2010 Centralised Orphan - Removal of orphan designation from Community Register